Lemaitre Vascular Inc
LMAT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001158895
No open-market purchases or sales by Lemaitre Vascular Inc insiders were filed in the last 90 days; 327 institutions reported holding it in 13F filings for Q2 2026, worth $2.20B in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Lemaitre Vascular Inc as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 291
- +31 vs. Q2 2024
- Shares held
- 21.0M
- +3.94M (+23.1%) vs. Q2 2024
- Total value
- $1.95B
- +$547.0M (+39.0%) vs. Q2 2024
- New holders
- 47
- 105 more added
- Sold out
- 16
- 95 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LMAT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 327 | $2.20B |
| Q1 2026 | 341 | $2.42B |
| Q4 2025 | 297 | $1.73B |
| Q3 2025 | 297 | $1.84B |
| Q2 2025 | 283 | $1.76B |
| Q1 2025 | 288 | $1.77B |
| Q4 2024 | 307 | $1.95B |
| Q3 2024 | 291 | $1.95B |
| Q2 2024 | 262 | $1.69B |
| Q1 2024 | 243 | $1.34B |
| Q4 2023 | 227 | $1.14B |
| Q3 2023 | 220 | $1.06B |
| Q2 2023 | 212 | $1.27B |
| Q1 2023 | 185 | $968.0M |
| Q4 2022 | 182 | $876.0M |
| Q3 2022 | 189 | $969.5M |
| Q2 2022 | 180 | $879.0M |
| Q1 2022 | 183 | $872.4M |
| Q4 2021 | 182 | $924.8M |
| Q3 2021 | 195 | $989.0M |
| Q2 2021 | 185 | $1.08B |
| Q1 2021 | 179 | $875.5M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Lemaitre Vascular Inc; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |
| Vestmark Advisory Solutions, Inc. | 0 | $0 | 0.00% | −2,638−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −2,150−100.0% | Sold out |
| Ashton Thomas Private Wealth, LLC | 0 | $0 | 0.00% | −1,968−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −253−100.0% | Sold out |
| Opal Wealth Advisors, LLC | 0 | $0 | 0.00% | −162−100.0% | Sold out |
| Innealta Capital, LLC | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |